In the course of a search for anti-dormant mycobacterial substances from marine-derived microorganisms, viomellein (1) and xanthomegnin (2) were rediscovered from the active fraction of the culture of a marine-derived Aspergillus sp. together with rubrosulphin (3) and asteltoxin (4) on the guidance of bioassay-guided separation. In particular, compound 1 showed higher activity against the dormant than against actively growing Mycobacterium bovis BCG and weak activity against M. smegmatis. Furthermore, evidence that compound 1 did not directly bind to plasmid DNA suggests its anti-mycobacterial activity differs from its direct chelating effect on the mycobacterial genome.
Tuberculosis is one of the most common causes of morbidity and mortality in adults who are HIV-positive and living in poverty. The World Health Organization (WHO) estimated that there were 1.5 million tuberculosis-related deaths in 2015. Similar to other infectious diseases, the appearance of multi-drug resistant strains is a problem associated with tuberculosis treatment. Moreover, the long-term chemotherapy required to cure effectively the disease is a considerable problem. One of the major reasons for the extended chemotherapeutic regimens and widespread epidemicity of tuberculosis is that the causative agent, M. tuberculosis, has an ability to revert to a state of dormancy [1] .
The marine environment is a rich source of drug leads because of its chemical and biological diversity. Numerous natural products or their derivatives have been reported as anti-mycobacterial substances. However, most previous studies focused on growthinhibitory activity against M. tuberculosis under active growing conditions [2] . Therefore, new lead compounds that are effective against M. tuberculosis in both its active and dormant states are urgently needed.
Although the pathology of the latent M. tuberculosis infection is still unclear, a hypoxic condition was found to induce the dormancy of Mycobacterium sp., which has a drug susceptibility profile resembling that of the latent M. tuberculosis infection [3] . Based on these findings, we have established a screening system to search for substances with antimicrobial activity against dormant mycobacteria. In this assay system, the minimum inhibitory concentration (MIC) values of isoniazid against M. smegmatis (a non-pathogenic strain of a fast growing type) and M. bovis Bacille Calmette-Guérin (BCG, a vaccine strain of a slow growing type) were 2.5 and 0.05 µg/mL, respectively under aerobic conditions, whereas the corresponding values were > 25 µg/mL under hypoxic conditions, as shown in Table 1 . To date, we have discovered some marine natural products such as trichoderins (new aminolipopeptides) [4] , neamphamide B (new cyclic depsipeptide) [5] , and 2-methoxy-3-oxoaaptamine (new aaptamine class alkaloid) [6] , as anti-dormant mycobacterial substances using the assay system system. The continuous screening of marine sponges and marinederived microorganisms led to the re-discovery of viomellein (1) [7] and xanthomegnin (2) [8, 9] as anti-dormant mycobacterial substances from the active fraction of the culture of a marinederived Aspergillus sp., together with rubrosulphin (3) [8, 10, 11] and asteltoxin (4) [12] following the bioassay-guided separation ( Figure 1 ). Although compound 3 has been reported as a natural product, compound 1 was easily transformed into compound 3 in MeOH solution.
Compound 1 exhibited potent anti-microbial activity against M. bovis BCG under both actively growing aerobic and dormancyinducing hypoxic conditions with MICs of 6.25 and 1.56 µg/mL, respectively, while the compound showed weak activity against M. smegmatis (Table 1) . Compound 1 has a tendency to affect M. bovis BCG under dormant rather than actively growing conditions. In contrast, compound 2 showed weak anti-microbial activity against both M. smegmatis and M. bovis BCG with MIC values of 12.5~50 µg/mL, while compounds 3 and 4 showed no effects at up to 200 µg/mL (Table 1 ). These results suggest that the phenolic hydroxy group at C-9 of compound 1 is important for its activity against M. bovis BCG. On the other hand, compound 1 was reported to show activities such as insecticidal [13] , inhibition of the addition of a small ubiquitin-like modifier (SUMOylation) [14] , and antimicrobial against several kinds of bacteria and fungi [9] , whereas no anti-mycobacterial activity has been reported for the compound.
In addition, compound 1 is also known as a mycotoxin, and to have weak genotoxic activity, as evaluated using the SOS chromotest against Escherichia coli K12 [15] . Therefore, we speculate that the anti-mycobacterial activity of compound 1 is caused by its effect on the mycobacterial genome. To confirm this speculation, we next investigated whether compound 1 binds to DNA using plasmid pMV206 ( Figure 2 ). Compound 1 was detected on the agarose gel at concentrations ranging from 3 to 30 µg/10 µL with a retention factor (Rf) of 0.58 (Figure 2A and C), while that of the plasmid pMV206 was calculated as 0.51 and 0.41 ( Figure 2B and C). Then, no significant reduction and band shift were observed in the DNAs ( Figure 2B ). This result suggests that compound 1 did not bind to the plasmid DNA directly and, therefore, its anti-mycobacterial activity might be different from its direct chelating effect on the mycobacterial genome. A study of the detailed mode of action of compound 1 is currently in progress. . bovis BCG) . After incubation, 50 µL of MTT solution (0.5 mg/mL) was added to each well and incubated at 37°C for an additional 12 h under aerobic or hypoxic conditions. The optical density at 560 nm was measured to determine the MIC value.
Experimental

Anti-mycobacterial activity under aerobic and hypoxic conditions:
Isolation of compounds 1-4 from marine-derived Aspergillus sp.:
The marine-derived Aspergillus sp. 02E28_2-2 was isolated from an unidentified marine sponge, which was collected at Sabang Island, Indonesia in 2014. The strain was cultured in rice medium (totally 250 g of unpolished rice and 500 mL of artificial sea water) under static condition at 30°C for 2 weeks. The culture was extracted with acetone and a mixed organic solvent of acetone/MeOH/EtOAc (4:2:1), and then the organic solvents were combined and evaporated under reduced pressure to obtain a crude extract. This was partitioned into a water/EtOAc mixture. Compounds 1-4 were identified by ESI-TOF-MS and 2D-NMR analyses and comparison with authentic spectral data [7] [8] [9] [10] [11] [12] .
DNA binding analysis of compound 1:
The binding of compound 1 to pMV206 of plasmid DNA was evaluated as described below. The indicated amounts of compound 1 were added to 10 µL TE buffer (10 mM Tris-HCl, pH 8.0, containing 1 mM EDTA) in the presence or absence of pMV206 (500 ng). Then, each reaction mixture was incubated at room temperature for 1 h; the samples were mixed with Anti-mycobacterial activity of marine-derived Aspergillus sp.
Natural Product Communications Vol. 12 (4) 2017 581 a DNA loading dye (NEB, #B7024S), and then subjected to agarose gel electrophoresis without boiling. After electrophoresis, the agarose gel was observed under UV conditions at 312 nm to detect compound 1 using the ImageQuant LAS4010 Digital Imaging System (GE Healthcare Life Sciences). In addition, the resolved DNAs were visualized using ethidium bromide staining. The retention factor (Rf) values of compound 1 and pMV206 were determined by analyzing each gel image using Adobe Photoshop.
